US SB2089 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 11 2019 - 25% progression, died in committee
Action: 2019-07-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 11 2019 - 25% progression, died in committee
Action: 2019-07-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to prohibit the labeling of certain opioid drugs recommending use for long-term chronic pain.
Title
FDA Opioid Labeling Accuracy Act
Sponsors
Sen. Joe Manchin [D-WV] | Sen. Mike Braun [R-IN] |
History
Date | Chamber | Action |
---|---|---|
2019-07-11 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Government studies and investigations
Health
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Government studies and investigations
Health
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/2089/all-info |
Text | https://www.congress.gov/116/bills/s2089/BILLS-116s2089is.pdf |